Equities

Anteris Technologies Global Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
AVR:ASX

Anteris Technologies Global Corp

Actions
Health CareMedical Equipment and Services
  • Price (AUD)7.78
  • Today's Change-0.21 / -2.63%
  • Shares traded16.07k
  • 1 Year change-21.49%
  • Beta--
Data delayed at least 20 minutes, as of Feb 10 2026 04:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.

  • Revenue in AUD (TTM)--
  • Net income in AUD--
  • Incorporated2024
  • Employees--
  • Location
    Anteris Technologies Global Corp860 Blue Gentian Road, Suite 340EAGAN 55121United StatesUSA
  • Phone+1 (651) 493-0606
  • Fax+1 (302) 636-5454
  • Websitehttps://anteristech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
EMvision Medical Devices Ltd5.63m-9.81m167.75m----16.63--29.80-0.1148-0.11480.06590.10860.2847--694.01---49.59-47.15-58.91-58.42-----174.21-105.97---93.340.2758---51.3141.83-259.23------
Lumos Diagnostics Holdings Ltd17.68m-10.24m210.20m----22.60--11.89-0.0149-0.01490.0260.01170.52057.044.91---30.15-40.19-54.60-61.1662.9552.57-57.93-132.460.6816-10.690.5315--11.4017.1216.40---61.58--
Aroa Biosurgery Ltd77.53m-1.56m241.83m261.00--3.05143.073.12-0.0045-0.00450.22470.22960.84321.563.08---1.70-8.53-1.85-9.7585.0782.71-2.01-15.205.740.31420.0706--22.6327.5664.12--14.62--
Orthocell Ltd8.85m-8.57m253.67m----15.62--28.66-0.0375-0.03750.03970.05990.28622.319.20---27.70-28.14-34.17-33.4768.9871.87-96.78-167.824.78--0.0381--36.4161.65-19.30--45.43--
Saluda Medical Inc-100.00bn-100.00bn301.17m--------------------------------------------------36.13---52.62------
EchoIQ Ltd101.41k-13.26m304.01m----13.18--2,997.84-0.0226-0.02260.00020.03530.0064--0.6446---83.87-68.78-89.84-81.95-----13,078.12-3,892.98----0.00--127.89-31.65-145.19---16.56--
Paragon Care Ltd3.62bn20.57m322.78m0.0015.700.97866.400.08920.01240.01242.180.19933.0211.9010.33--1.721.794.474.079.048.900.56880.60810.61551.770.4699--21.7273.23151.52--18.34--
EBR Systems Inc971.91k-63.88m351.03m----6.37--361.18-0.1706-0.17060.00260.12250.0074--0.4935---48.75-60.71-53.75-74.7645.20---6,572.14--7.01-15.000.5131-------16.44--2.46--
Imricor Medical Systems Inc1.07m-51.28m613.01m----18.60--574.48-0.1897-0.18970.00390.10270.02371.132.64---113.72-103.39-123.12-119.90-133.44-154.65-4,806.09-2,687.8525.62-1.110.5073--55.868.44-31.23---26.55--
Polynovo Ltd127.73m13.21m652.85m301.0049.557.8441.035.110.01910.01910.18370.12051.080.3675.88424,352.2011.192.1714.292.7196.6394.8910.352.102.257.870.17070.0021.9641.91151.17--9.45--
Anteris Technologies Global Corp-100.00bn-100.00bn717.77m---------------------------------------------------1.16---65.77------
Nanosonics Ltd.198.63m20.68m1.15bn470.0056.675.4840.005.790.06690.06690.64250.69130.77922.235.05422,612.808.116.489.457.5378.2277.9310.418.695.19--0.03530.0016.8314.7059.3915.3235.13--
4DMedical Ltd5.85m-30.07m1.97bn----25.08--336.81-0.0714-0.07140.01380.1380.05450.48580.8787---27.99-32.98-34.63-40.3892.0786.20-513.72-1,237.520.8383--0.0629--55.9136.5616.42--3.07--
Data as of Feb 10 2026. Currency figures normalised to Anteris Technologies Global Corp's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.